Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: In vivo evidence, molecular targets, and clinical relevance

Current Cancer Drug Targets

Volumn 12, Issue 9, 2012, Pages 1191-1232

  Bishayee, Anupam ^a,b   Thoppil, Roslin J ^a   Waghray, Abhijeet ^a   Kruse, Jaclyn A ^a   Novotny, Nicholas A ^a   Darvesh, Altaf S ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b Northeastern Ohio Medical University   (United States)

Author keywords

Chemoprevention; Dietary; Hepatocarcinogenesis; Hepatocellular carcinoma; Liver cancer; Phytochemicals; Treatment

Indexed keywords

3 INDOLEMETHANOL; ACETYLCYSTEINE; ALLYL SULFIDE; ANTHOCYANIN; APIGENIN; BETACYANIN; BETALAIN; BLACK TEA EXTRACT; CAFFEIC ACID; CAFFEINE; CHRYSIN; COUMARIN; DIALLYL DISULFIDE; DIALLYL TRISULFIDE; GARLIC EXTRACT; GENISTEIN; GREEN TEA EXTRACT; HESPERIDIN; INDOLEACETIC ACID; MORIN; NOBILETIN; PIPERIDINE DERIVATIVE; PLANT MEDICINAL PRODUCT; POLYPHENOL; QUERCETIN; S ALLYLCYSTEINE; S METHYLCYSTEINE; SILIBININ; SILYMARIN; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; CHEMOPROPHYLAXIS; COFFEE; DIET; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; HUMAN; INFLAMMATION; LIVER CELL CARCINOMA; MOLECULARLY TARGETED THERAPY; NONHUMAN; OXIDATIVE STRESS; PHOTOCHEMISTRY; REVIEW;

EID: 84872578889     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/15680096112091191     Document Type: Review

References (281)

1. El-Serag, H. B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127, S27-S34.
2. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62, 10-29.
3. Bartsch, H.; Montesano R. Relevance of nitrosamines to human cancer. Carcinogenesis 1984, 5, 1381-1393.
4. Kensler, T. W.; Egner, P. A.; Wang, J. B.; Zhu, Y. R.; Zhang, B. C.; Lu, P. X.; Chen, J. G.; Qian, G. S.; Kuang, S. Y.; Jackson, P. E.; Gange, S. J.; Jacobson, L. P.; Muñoz, A.; Groopman, J. D. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology 2004, 127, S310-318.
5. Pang, R.; Tse, E.; Poon, R. T. Molecular pathways in hepatocellular carcinoma. Cancer Lett. 2006, 240, 157-169.
6. Schütte, K.; Bornschein, J.; Malfertheiner, P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig. Dis. 2009, 27, 80-92.
7. Hoshida, Y.; Toffanin, S.; Lachenmayer, A.; Villanueva, A.; Minguez, B.; Llovet, J. M. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin. Liver Dis. 2010, 30, 35-51.
8. Whittaker, S.; Marais, R.; Zhu, A. X. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010, 29, 4989-5005.
9. Simile, M. M; Frau, M.; Pascale, R. M.; Feo, F. New putative prognostic markers and therapeutic targets for the molecular approach to treatment of hepatocellular carcinoma. J. Expt. Integ. Med. 2011, 1, 85-97.
10. Llovet, J. M.; Burroughs, A.; Bruix, J. Hepatocellular carcinoma. Lancet 2003, 362, 1907-1917.
11. Senthil, M.; Mailey, B.; Leong, L.; Chung, V.; Yen, Y.; Chen, Y-J.; Marx, H.; Kim, J. Liver-directed regional therapy in the multidisciplinary management of hepatocellular cancer. Curr. Cancer Ther. Rev. 2010, 6, 19-25.
12. Llovet, J. M.; Ricci, S.; Mazzaferro, V.; Hilgard, P.; Gane, E.; Blanc, J. F.; de Oliveira, A. C.; Santoro, A.; Raoul, J. L.; Forner, A.; Schwartz, M.; Porta, C.; Zeuzem, S.; Bolondi, L.; Greten, T. F.; Galle, P. R.; Seitz, J. F.; Borbath, I.; Häussinger, D.; Giannaris, T.; Shan, M.; Moscovici, M.; Voliotis, D.; Bruix, J. SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N. Eng. J. Med. 2008, 359, 378-390.
13. Lu S. C. Where are we in the chemoprevention of hepatocellular carcinoma? Hepatology 2010, 51, 734-736.
14. Je, Y.; Schutz, F. A. B.; Choueiri, T. K. Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and mataanalysis of clinical trials. Lancet Oncol. 2009, 10, 967-974.
15. Thomas, M. B.; Jaffe, D.; Choti, M. M.; Belghiti, J.; Curley, S.; Fong, Y.; Gores, G.; Kerlan, R.; Merle, P.; O'Neil, B.; Poon, R.; Schwartz, L.; Tepper, J.; Yao, F.; Haller, D.; Mooney, M.; Venook A. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J. Clin. Oncol. 2010, 28, 3994-4005.
16. Kris-Etherton, P. M.; Hecker, K. D.; Bonanome, A.; Coval, S. M.; Binkoski, A. E.; Hilpert, K. F.; Griel, A. E.; Etherton, T. D. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002, 113, 71S-88S.
17. Riboli, E.; Norat, T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am. J. Clin. Nutr. 2003, 78, 559S-569S.
18. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR: Washington, DC, 2007.
19. Aggarwal, B. B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 2006, 71, 1397-1421.
20. Stan, S. D.; Kar, S.; Stoner, G. D.; Singh, S. V. Bioactive food components and cancer risk reduction. J. Cell. Biochem. 2008, 104, 339-356.
21. Kaefer, C. M.; Milner, J. A. The role of herbs and spices in cancer prevention. J. Nutr. Biochem. 2008, 19, 347-361.
22. Gullett, N. P.; Ruhul Amin, A. R.; Bayraktar, S.; Pezzuto, J. M.; Shin, D. M.; Khuri, F. R.; Aggarwal, B. B.; Surh, Y. J.; Kucuk, O. Cancer prevention with natural compounds. Semin. Oncol. 2010, 37: 258-281.
23. Huang, W. Y.; Cai, Y. Z.; Zhang, Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr. Cancer 2010, 62, 1-20.
24. Bishayee, A. Editorial: current advances in cancer prevention and treatment by natural products. Curr. Pharm. Biotechnol. 2012, 13, 115-116.
25. Mann, C. D.; Neal, C. P.; Garcea, G.; Manson, M. M.; Dennison, A. R.; Berry, D. P. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur. J. Cancer Prev. 2009, 18, 13-25.
26. Glauert, H. P.; Mason-Calfee, K.; Stemm, D. V.; Tharappel, J. C. Dietary antioxidants in the prevention of hepatocarcinogenesis: a review. Mol. Nutr. Food Res. 2010, 54, 875-896.
27. Lagopoulos, L.; Sunahara, G. I.; Würzner, H.; Fliesen, T.; Stalder, R. The correlation of body growth with diethylnitrosamine-induced hepatocarcinogenesis in relation to serum insulin and somatomedin-C. Carcinogenesis 1991, 12, 211-215.
28. Kim, S. H.; Lee, C. S. The effect of caffeine on diethylnitrosamineinitiated hepatic altered foci in a mid-term induction system. In Vivo 1992, 6, 223-226.
29. Chung, F. L.; Wang, M.; Rivenson, A.; Iatropoulos, M. J.; Reinhardt, J. C.; Pittman, B.; Ho, C. T.; Amin, S. G. Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res. 1998, 58, 4096-4101.
30. Hosaka, S.; Kawa, S.; Aoki, Y.; Tanaka, E.; Yoshizawa, K.; Karasawa, Y.; Hosaka, N.; Kiyosawa, K. Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene. Food Chem. Toxicol. 2001, 39, 557-561.
31. Fujise, Y.; Okano, J. I.; Nagahara, T.; Abe, R.; Imamoto, R.; Murawaki, Y. Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats. Int. J. Oncol. 2012, 40, 1779-1788.
32. Kuribayashi, M.; Asamoto, M.; Suzuki, S.; Hokaiwado, N.; Ogawa, K.; Shirai, T. Lack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) rat hepatocarcinogenesis by caffeine, a CYP1A2 inducer, points to complex counteracting influences. Cancer Lett. 2006, 232, 289-299.
33. Tanaka, T.; Nishikawa, A.; Shima, H.; Sugie, S.; Shinoda, T.; Yoshimi, N.; Iwata, H.; Mori, H. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci. 1990, 52, 429-440.
34. Silva-Oliveira, E. M.; Fernandes, P. A.; Moraes-Santos, T. Effect of coffee on chemical hepatocarcinogenesis in rats. Nutr. Cancer 2010, 62, 336-342.
35. Miura, Y.; Ono, K.; Okauchi, R.; Yagasaki, K. Inhibitory effect of coffee on hepatoma proliferation and invasion in culture and on tumor growth, metastasis and abnormal lipoprotein profiles in hepatoma-bearing rats. J. Nutr. Sci. Vitaminol. 2004, 50, 38-44.
36. Kitano, M.; Wanibuchi, H.; Kikuzaki, H.; Nakatani, N.; Imaoka, S.; Funae, Y.; Hayashi, S.; Fukushima, S. Chemopreventive effects of coumaperine from pepper on the initiation stage of chemical hepatocarcinogenesis in the rat. Jpn. J. Cancer Res. 2000, 91, 674-680.
37. Schwartz, S.; Von Elbe, J.; Pariza, M.; Goldsworthy, T.; Pitot, H. C. Inability of red beet betalain pigments to initiate or promote hepatocarcinogenesis. Food Chem. Toxicol. 1983, 21, 531-535.
38. Kapadia, G. J.; Azuine, M. A.; Sridhar, R.; Okuda, Y.; Tsuruta, A.; Ichiishi, E.; Mukainake, T.; Takasaki, M.; Konoshima, T.; Nishino, H.; Tokuda, H. Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot. Pharmacol. Res. 2003, 47, 141-148.
39. Park, K. C.; Kim, S. Y.; Kim, D. S. Experimental photodynamic therapy for liver cancer cell-implanted nude mice by an indole-3-acetic acid and intense pulsed light combination. Biol. Pharm. Bull. 2009, 32, 1609-1613.
40. 1 carcinogenesis in rainbow trout by flavone and indole compounds. Carcinogenesis 1984, 5, 615-619.
41. Bailey, G.; Selivonchick, D.; Hendricks, J. Initiation, promotion, and inhibition of carcinogenesis in rainbow trout. Environ. Heath Perspect. 1987, 71, 147-153.
42. 1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency. Cancer Res. 1991, 51, 2362-2365.
43. 1-initiated hepatocarcinogenesis: results from a 9000 animal tumor study. Carcinogenesis 1999, 20, 453-458.
44. 1-induced carcinogenesis by indole-3-carbinol in rat liver-predicting the outcome using early biomarkers. Carcinogenesis 1998, 19, 1829-1836.
45. Stoner, G.; Casto, B.; Ralston, S.; Roebuck, B.; Pereira, C.; Bailey, G. Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol. Carcinogenesis 2002, 23, 265-272.
46. Tanaka, T.; Mori, Y.; Morishita, Y.; Hara, A.; Ohno, T.; Kojima, T.; Mori, H. Inhibitory effect of sinigrin and indole-3-carbinol on diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats. Carcinogenesis 1990, 11, 1403-1406.
47. Kim, D. J.; Lee, K. K.; Han, B. S.; Ahn, B.; Bae, J. H.; Jang, J. J. Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats. Jpn. J. Cancer Res. 1994, 85, 578-583.
48. Oganesian, A.; Hendricks, J. D.; Williams, D. E. Long term dietary indole-3-carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model. Cancer Lett. 1997, 118, 87-94.
49. Shukla, Y.; Kalra, N.; Katiyar, S.; Siddiqui, I.A.; Arora, A. Chemopreventive effect of indole-3-carbinol on induction of preneoplastic altered hepatic foci. Nutr. Cancer 2004, 50, 214-220.
50. Shimamoto, K.; Dewa, Y.; Ishii, Y.; Kemmochi, S.; Taniai, E.; Hayashi, H.; Imaoka, M.; Morita, R.; Kuwata, K.; Suzuki, K.; Shibutani, M.; Mitsumori, K. Indole-3-carbinol enhances oxidative stress responses resulting in the induction of preneoplastic liver cell lesions in partially hepatectomized rats initiated with diethylnitrosamine. Toxicology 2011, 283, 109-117.
51. 1-induced carcinogenesis in the toad Bufo regularis. Nutr. Cancer 1994, 21, 95-100.
52. Soni, K. B.; Lahiri, M.; Chackradeo, P.; Bhide, S. V.; Kuttan, R. Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Lett. 1997, 115, 129-133.
53. Samaranayake, M. D. P.; Wickramaninghe, S. M. D. N.; Angunawela, P.; Jayasekera, S.; Iwai, S.; Fukushima, S. Inhibition of chemically induced liver carcinogenesis in Wistar rats by garlic (Allium sativum). Phytother. Res. 2000, 14, 564-567.
54. Park, K. A.; Kweon, S.; Choi, H. Anticarcinogenic effect and modification of cytochrome P4502E1 by dietary garlic powder in diethylnitrosamine-initiated rat hepatocarcinogenesis. J. Biochem. Mol. Biol. 2002, 35, 615-622.
55. Kweon, S.; Park, K. A.; Choi, H. Chemopreventive effect of garlic powder diet in diethylnitrosamine-induced rat hepatocarcinogenesis. Life Sci. 2003, 73, 2515-2526.
56. Zhang, C. L.; Zeng, T.; Zhao, X. L.; Yu, L. H.; Zhu, Z. P.; Xie, K. Q. Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats. Int. J. Biol. Sci. 2012, 8, 363-374.
57. 1 carcinogenicity in rats. Carcinogenesis 2004, 25, 1953-1959.
58. Hayes, M. A.; Rushmore, T. H.; Goldberg, M. T. Inhibition of hepatocarcinogenic responses to 1, 2-dimethylhydrazine by diallyl sulfide, a component of garlic oil. Carcinogenesis 1987, 8, 1155-1157.
59. Tsuda, H.; Uehara, N.; Iwahori, Y.; Asamoto, M.; Igo, M.; Nagao, M.; Matsumoto, K.; Ito M.; Hirono, I. Chemopreventive effects of-carotene, α-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo [4,5-f]quinoline in the rat. Jpn. J. Cancer Res. 1994, 85, 1214-1219.
60. Pereira, M. A. Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice. Anticancer Res. 1995, 15, 1953-1956.
61. 1-and N-nitrosodiethylamineinduced liver preneoplastic foci in rats fed naturally occurring allyl sulfides. Nutr. Cancer 1996, 25, 61-70.
62. Singh, A.; Arora, A.; Shukla, Y. Modulation of altered hepatic foci induction by diallyl sulphide in Wistar rats. Eur. J. Cancer Prev. 2004, 13, 263-269.
63. Abdel-Hamid, N. M.; Nazmy, M. H.; Abdel-Bakey, A. I. Polyol profile as an early diagnostic and prognostic marker in natural product chemoprevention of hepatocellular carcinoma in diabetic rats. Diabetes Res. Clin Pract. 2011, 92, 228-237.
64. Takada, N.; Matsuda, T.; Otoshi, T.; Yano, Y.; Otani, S.; Hasegawa, T.; Nake, D.; Konishi, Y.; Fukushima, S. Enhancement by organosulfur compounds from garlic and onions of diethylnitrosamine-induced glutathione S-transferase positive foci in the rat liver. Cancer Res. 1994, 54, 2895-2899.
65. Fukushima, S.; Takada, N.; Hori, T.; Wanibuchi, H. Cancer chemoprevention by organosulfur compounds from garlic and onion. J. Cell Biochem. 1997, 27, 100-105.
66. Guyonnet, D.; Bergès, R.; Siess, M. H.; Pinnert, M. F.; Chagnon, M. C.; Suschetet, M.; Le Bon, A. M. Post-initiation modulating effects of allyl sulfides in rat hepatocarcinogenesis. Food Chem. Toxicol. 2004, 42, 1479-1485.
67. Zhang, Z. M.; Yang, X. Y.; Deng, S. H.; Xu, W.; Gao, H. Q. Antitumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Chin. Med. J. 2007, 120, 1336-1342.
68. Takada, N.; Kitano, M.; Chen, T.; Yano, Y.; Otani, S.; Fukushima, S. Enhancing effects of organosulfur compounds from garlic and onions on hepatocarcinogenesis in rats: association with increased cell proliferation and elevated ornithine decarboxylase activity. Jpn. J. Cancer Res. 1994, 85, 1067-1072.
69. Matsuda, T.; Takada, N.; Yano, Y.; Wanibuchi, H.; Otani, S.; Fukushima, S. Dose-dependent inhibition of glutathione Stransferase placental form-positive hepatocellular foci induction in the rat by methyl propyl disulfide and propylene sulfide from garlic and onions. Cancer Lett. 1994, 86, 229-234.
70. Nishikawa-Ogawa, M.; Wanibuchi, H.; Morimura, K.; Kinoshita, A.; Nishikawa, T.; Hayashi, S.; Yano, Y.; Fukushima, S. Nacetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage. Carcinogenesis 2006, 27, 982-988.
71. Uda, N.; Kashimoto, N.; Sumioka, I.; Kyo, E.; Sumi, S.; Fukushima, S. Aged garlic extract inhibits development of putative preneoplastic lesions in rat hepatocarcinogenesis. J. Nutr. 2006, 136, 855S-860S.
72. Sundaresan, S.; Subramanian, P. S-Allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in Nnitrosodiethylamine-induced carcinogenesis. Pol. J. Pharmacol. 2003, 55, 37-42.
73. Sundaresan, S.; Subramanian, P. Prevention of Nnitrosodiethylamine-induced hepatocarcinogenesis by Sallylcysteine. Mol. Cell. Biochem. 2008, 310, 209-214.
74. Watanabe, T.; Sugie, S.; Okamoto, K.; Wahidur, R. K. M.; Ushida, J.; Mori, H. Chemopreventive effects of scordinin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. Jpn. J. Cancer Res. 2001, 92, 603-609.
75. Fukushima, S.; Takada, N.; Wanibuchi, H.; Hori, T.; Min, W.; Ogawa, M. Suppression of chemical carcinogenesis by watersoluble organosulfur compounds. J. Nutr. 2001, 131, 1049S-1053S.
76. Matsumoto, N.; Kohri, T.; Okushio, K.; Hara Y. Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat. Jpn. J. Cancer Res. 1996, 87, 1034-1038.
77. Murugan, R. S.; Uchida, K.; Hara, Y.; Nagini, S. Black tea polyphenols modulate xenobiotic-metabolizing enzymes, oxidative stress and adduct formation in a rat hepatocarcinogenesis model. Free Radical Res. 2008, 42, 873-884.
78. Murugran, R. S.; Vinothini, G.; Hara, Y.; Nagini, S. Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model. Anticancer Res. 2009, 29, 2301-2306.
79. Murugan, R. S.; Priyadarsini, R. V.; Ramalingam, K.; Hara, Y.; Karunagaran, D.; Nagini, S. Intrinsic apoptosis and NF-B signaling are potential molecular targets for chemoprevention by black tea polyphenols in HepG2 cells in vitro and in a rat hepatocarcinogenesis model in vivo. Food Chem. Toxicol. 2010, 48, 3281-3287.
80. 1-induced γ-glutamyltranspeptidase positive hepatocyte foci in rats. Zhonghua Zhong Liu Za Zhi 1987, 9, 109-111.
81. Cao, J.; Xu, Y.; Chen, J.; Klaunig, J. E. Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis. Fundam. Appl. Toxicol. 1996, 29, 244-250.
82. 1 in rat liver. Food Chem. Toxicol. 2009, 47, 220-229.
83. Srivastava, S.; Singh, M.; Roy, P.; Prasad, S.; George, J.; Shukla, Y. Inhibitory effect of tea polyphenols on hepatic preneoplastic foci in Wistar rats. Invest. New Drugs 2009, 27, 526-533.
84. Li, Y. Comparative study on the inhibitory effect of green tea, coffee and levamisole on the hepatocarcinogenic action of diethylnitrosamine. Zhonghua Zhong Liu Za Zhi 1991, 13, 193-195.
85. 1. In Relevance to Human Cancer of N-Nitroso Compound; O'Neil, I.K.; Chen, J.; Bartsch, H.; Eds. International Agency for Research on Cancer: Lyon, 1991, pp. 431-433.
86. 1-induced initiation of hepatocarcinogenesis in the rat by green tea. Cancer Lett. 1997, 112, 149-154.
87. 1-initiated and carbon tetrachloride-promoted hepatocarcinogenesis in the rat by green tea. Nutr. Cancer 2000, 38, 215-222.
88. Zhang, G.; Miura, Y.; Yagasaki, K. Effects of dietary powdered green tea and theanine on tumor growth and endogenous hyperlipidemia in hepatoma-bearing rats. Biosci. Biotechnol. Biochem. 2002, 66, 711-716.
89. Hirose, M.; Hoshiya, T.; Akagi, K.; Takahashi, S.; Hara, Y.; Ito, N. Effects of green tea catechins in a rat multi-organ carcinogenesis model. Carcinogenesis 1993, 14, 1549-1553.
90. Hirose, M.; Hasegawa, R.; Kimura, J.; Akagi, K.; Yoshida, Y.; Tanaka, H.; Miki, T.; Satoh, T.; Wakabayashi, K.; Ito, N.; Shirai, T. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis 1995, 16, 3049-3055.
91. Hirose, M.; Ito, T.; Takahashi, S.; Ozaki, M.; Ogiso, T.; Nihro, Y.; Miki, T.; Shirai, T. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments. Eur. J. Cancer Prev. 1998, 7, 61-77.
92. Tamura, K.; Nakae, D.; Horiguchi, K.; Akai, H.; Kobayashi, Y.; Satoh, H.; Tsujiuchi, T.; Denda, A.; Konishi, Y. Inhibition by green tea extract of diethylnitrosamine-initiated but not cholinedeficient, L-amino acid-defined diet-associated development of putative preneoplastic, glutathione S-transferase placental formpositive lesions in rat liver. Jpn. J. Cancer Res. 1997, 88, 356-362.
93. Umemura, T.; Kai, S.; Hasegawa, R.; Kanki, K.; Kitamura, Y.; Nishikawa, A.; Hirose, M. Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamine-induced hepato-and colangiocarcinogenesis in mice by green tea infusion. Carcinogenesis 2003, 24, 1105-1109.
94. Kim, H. S.; Kim, H. S.; Choi, H. Pre-and post-initiation modulating effects of green tea ingestion on rat hepatocarcinogenesis. Nutr. Res. Practice 2008, 2, 234-239.
95. Shimizu, M.; Sakai, H.; Shirakami, Y.; Yasuda, Y.; Kubota M.; Terakura, D.; Baba, A.; Ohno, T.; Hara, Y.; Tanaka, T.; Moriwaki, H. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Prev. Res. 2011, 4, 396-403.
96. Tharappel, J. C.; Lehmler, H. J.; Srinivasan, C.; Robertson, L. W.; Spear, B. T.; Glauert, H. P. Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3',4,4'-tetrachlorobiphenyl (PCB-77). Food Chem. Toxicol. 2008, 46, 3467-3474.
97. Nishida, H.; Omori, M.; Fukutomi, Y.; Ninomiya, M.; Nishiwaki, S.; Suganuma, M.; Moriwaki, H.; Muto, Y. Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells. Jpn. J. Cancer Res. 1994, 85, 221-225.
98. Nishikawa, T.; Nakajima, M.; Moriguchi, M.; Jo, M.; Sekoguchi, S.; Ishii, M.; Takashima, H.; Katagishi, T.; Kimura, M.; Minami, M.; Itoh, Y.; Kagawa, K.; Okanoue, T. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J. Hepatol. 2006, 44, 1074-1082.
99. Shirakami, Y.; Shimizu, M.; Adachi, S.; Sakai, H.; Nakagawa, T.; Yasuda, Y.; Tsurumi, H.; Hara, Y.; Moriwaki, H. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. Cancer Sci. 2009, 10, 1957-1962.
100. Roomi, M. W.; Roomi, N. W.; Kalinovsky, T.; Niedzwiecki, A.; Rath, M. In vivo and in vitro effect of a nutrient mixture on human hepatocarcinoma cell line SK-Hep-1. Exp. Oncol. 2010, 32, 84-91.
101. Liang, G.; Tang, A.; Lin, X.; Li, L.; Zhang, S.; Huang, T.; Tang, H.; Li, Q. Q. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int. J. Oncol. 2010, 37, 111-123.
102. Khan, M. S.; Devaraj, H.; Devaraj, N. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in Nnitrosodiethylamine-induced preneoplastic nodules in rats. Toxicol. Appl. Pharmacol. 2011, 251, 85-94.
103. Khan M. S.; Halagowder, D.; Devaraj, S. N. Methylated chrysin, a dimethoxy flavone, partially suppresses the development of liver preneoplastic lesions induced by N-nitrosodiethylamine in rats. Food Chem. Toxicol. 2011, 49, 173-178.
104. Khan, M. S.; Halagowder, D.; Devaraj, S. N. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-κB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model. Chem. Biol. Interact. 2011, 193, 12-21.
105. Kroll, D. J.; Shaw, H. S.; Oberlies, N. H. Milk thistle nomencleature: why it matters in cancer research and pharmacokinetic studies. Integr. Cancer Ther. 2007, 6, 110-119.
106. Abenavoli, L.; Capasso, R.; Milic, N.; Capasso, F. Milk thistle in liver diseases: past, present, future. Phytother. Res. 2010, 10, 1423-1432.
107. Ramakrishnan, G.; Raghavendran, H. R. B.; Vinodhkumar, R.; Devaki, T. Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chem. Biol. Interact. 2006, 161, 104-114.
108. Pradeep, K.; Raj, Mohan, C. V.; Gobianand, K.; Karthikeyan, S. Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats. Eur. J. Pharmacol. 2007, 560, 110-116.
109. Ramakrishnan, G.; Augustine, T. A.; Jagan, S.; Vinodhkumar, R.; Devaki, T. Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Exp. Oncol. 2007, 29, 39-44.
110. Ramakrishnan, G.; Elinos-Báez, C. M.; Jagan, S.; Augustine, T. A.; Kamaraj, S.; Anandakumar, P.; Devaki, T. Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma. Mol. Cell. Biochem. 2008, 313, 53-61.
111. Ramakrishnan, G.; Jagan, S.; Kamaraj, S.; Anandakumar, P.; Devaki, T. Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis. Invest. New Drugs 2009, 27, 233-240.
112. El Mesallamy, H. O.; Metwally, N. S.; Soliman, M. S.; Ahmed, K. A.; Abdel Moaty, M. M. The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats. Cancer Cell Int. 2011, 11, 38.
113. Wu, Y.; Fu, S. L.; Kao, C. H.; Yang, C. W.; Lin, C. H.; Hsu, M. T.; Tsai, T. F. Chemopreventive effect of silymarin of liver pathology in HBV X protein transgenic mice. Cancer Res. 2008, 68, 2033-2042.
114. Cui, W; Gu, F; Hu, K. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J. Gastroenterol. 2009, 15, 1943-1950.
115. Jeyabal, P. V. S.; Syed, M. B.; Venkataraman, M.; Sambandham, J. K.; Sakthisekaran, D. Apigenin inhibits oxidative stress-induced macromolecular damage in N-nitrosodiethylamine (NDEA)-induced hepatocellular carcinogenesis in Wistar albino rats. Mol. Carcinog. 2005, 44, 11-20.
116. Ohnishi, H.; Asamoto, M.; Tujimura, K.; Hokaiwado, N.; Takahashi, S.; Ogawa, K.; Kuribayashi, M.; Ogiso, T.; Okuyama, H.; Shirai, T. Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Sci. 2004, 95, 936-942.
117. Wang, L. S.; Stoner, G. D. Anthocyanins and their role in cancer prevention. Cancer Lett. 2008, 269, 281-290.
118. Thomasset, S.; Teller, N.; Cai, H.; Marko, D.; Berry, D. P.; Steward, W. P.; Gescher, A. J. Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs? Cancer Chemother. Pharmacol. 2009, 64, 201-211.
119. Bishayee, A.; Mbimba, T.; Thoppil R. J.; Háznagy-Radnai, E.; Sipos, P.; Darvesh, A. S.; Folkesson, H.; Hohmann, J. Anthocyaninrich black currant (Ribes nigrum L.) extract affords chemoprevention against diethylnitrosamine-induced hepatocellular carcinogenesis in rats. J. Nutr. Biochem. 2011, 22, 1035-1046.
120. Bishayee, A.; Thoppil, R. J.; Mandal, A.; Darvesh, A. S.; Ohanyan, V.; Meszaros, J. G.; Háznagy-Radnai, E.; Hohmann, J.; Bhatia, D. Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory response. Mol. Carcinog. 2012, in press. PMID: 22213170
121. Thoppil, R. J.; Bhatia, D.; Barnes, K. F.; Háznagy-Radnai, E.; Hohmann, J.; Darvesh, A. S.; Bishayee, A. Black currant anthocyanins abrogate oxidative stress through Nrf2-mediated antioxidant mechanisms in a rat model of hepatocellular carcinoma. Current Cancer Drug Targets 2012, 12, Epub Ahead of Schedule PMID: 22873222.
122. Sivaramakrishnan, V.; Shilpa, P. N. M.; Kumar, V. R. P.; Devaraj, S. N. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-morin. Chem. Biol. Interact. 2008, 171, 79-88.
123. Sivaramakrishnan, V.; Devaraj, S. N. Morin regulates the expression of NF-B-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem. Biol. Interact. 2009, 180, 353-359.
124. Sivaramakrishnan, V.; Devaraj, S. N. Morin fosters apoptosis in experimental hepatocellular carcinoma model. Chem. Biol. Interact. 2010, 183, 284-292.
125. Akagi, K.; Hirose, M.; Hoshiya, T.; Mizoguchi, Y.; Ito, N.; Shirai, T. Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett. 1995, 94, 113-121.
126. Sánchez-Pérez, Y.; Carrasco-Legleu, C.; García-Cuellar, C.; Pérez-Carreón, J.; Hernández-García, S.; Salcido-Neyoy, M.; Alemán-Lazarini, L.; Villa-Treviño, S. Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett. 2005, 217, 25-32.
127. Mandal, A. K.; Das, S.; Mitra, M.; Chakrabarti, R. N.; Chatterjee, M.; Das, N. Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model. J. Exp. Ther. Oncol. 2008, 7, 123-133.
128. Oi, N.; Hashimoto, T.; Kanazawa, K. Metabolic conversion of dietary quercetin from its conjugate to active aglycone following the induction of hepatocarcinogenesis in Fischer 344 rats. J. Agric. Food. Chem. 2008, 56, 577-583.
129. Seufi, A. M.; Ibrahim, S. S.; Elmaghraby, T. K.; Hafex, E. E. Preventive effect of the flavonoid, quercitin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences. J. Exp. Clin. Cancer Res. 2009, 28, 80.
130. Vasquez-Garzón, V.R.; Arellanes-Robledo, J.; Garcia-Roman, R.; Aparico-Bautista, D.I.; Villa-Treviňo, S. Inhibition of reactive oxygen species and pre-neoplastic lesions by quercetin through and antioxidant defense mechanism. Free Radic. Res. 2009, 43, 128-137.
131. Gupta, C.; Tripathi, D.N.; Vikram, A.; Ramarao, P.; Jena, G.B. Quercetin inhibits diethylnitrosamine-induced hepatic preneoplastic lesions in rats. Nutr. Cancer 2011, 63, 234-241.
132. Ghosh, A.; Ghosh, D.; Sarkar, S.; Mandal, A. K.; Thakur Choudhury, S.; Das, N. Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamineinduced hepatocarcinoma in rats. Eur. J. Cancer Prev. 2012, 21, 32-41.
133. Yuan, Z. P.; Chen, L. J.; Fan, L. Y.; Tang, M. H.; Yang, G. L.; Yang, H. S.; Du, X. B.; Wang, G. Q.; Yao, W. X.; Zhao, Q. M.; Ye, B.; Wang, R; Diao, P.; Zhang, W.; Wu, H. B.; Zhao, X.; Wei, Y. Q. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin. Cancer Res. 2006, 12, 3193-3199.
134. Yokohira, M.; Yamakawa, K.; Saoo, K.; Matsuda, Y.; Hosokawa, K.; Hashimoto, N.; Kuno, T.; Imaida, K. Antioxidant effects of flavonoids used as food additives (purple corn color, enzymatically modified isoquercitrin, and isoquercitrin) on liver carcinogenesis in a rat medium-term bioassay. J. Food Sci. 2008, 73, 561-568.
135. Hirose, M.; Takahashi, S.; Ogawa, K.; Futakuchi, M.; Shirai, T. Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis. Food Chem. Toxicol. 1999, 37, 985-992.
136. Chodon, D.; Banu, M. S.; Padmavathi, R.; Sakthisekaran, D. Inhibition of cell proliferation and induction of apoptosis by genistein in experimental hepatocellular carcinoma. Mol. Cell. Biochem. 2007, 297, 73-80.
137. Gu, Y.; Zhu, C.; Iwamoto, H.; Chen, J. S. Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J. Gasteroenterol. 2005, 11, 6512-5517.
138. Gu, Y.; Zhu, C. F.; Dai, Y.L.; Zhong, Q.; Sun, B. Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma. World J. Gastroenterol. 2009, 15, 4952-4957.
139. Jiang, H.; Ma, Y.; Chen, X.; Pan, S.; Sun, B.; Krissansen, G. W.; Sun, X. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Cancer Sci. 2010, 101, 975-983.
140. Ma, Y.; Wang, J.; Liu, L.; Zhu, H.; Chen, X.; Pan, S.; Sun, X.; Jiang, H. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB. Cancer Lett. 2011, 301, 75-84.
141. Carrasco-Legleu, C. E.; Márquez-Rosado, L.; Fattel-Fazenda, S.; Arce-Popoca, E.; Pérez-Carreón, J. I.; Villa-Treviño, S. Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay. Int. J. Cancer 2004, 108, 488-492.
142. Carrasco-Legleu, C. E.; Sánchez-Pérez, Y.; Márquez-Rosado, L.; Fattel-Fazenda, S.; Arce-Popoca, E.; Hernández-García, S.; Villa-Treviño, S. A single dose of caffeic acid phenethyl ester prevents initiation in a medium-term rat hepatocarcinogenesis model. World J. Gastroenterol. 2006, 12, 6779-6785.
143. Beltrán-Ramírez, O.; Alemán-Lazarini, L.; Salcido-Neyoy, M.; Hernández-García, S.; Fattel-Fazenda, S.; Arce-Popoca, E.; Arellanes-Robledo, J.; García-Román, R.; Vázquez-Vázquez, P.; Sierra-Santoyo, A.; Villa-Treviño, S. Evidence that the anticarcinogenic effect of caffeic acid phenethyl ester in the resistant hepatocyte model involves modifications of cytochrome P450. Toxicol. Sci. 2008, 104, 100-106.
144. Said, R. A.; Grassi, T. F.; Scolastici, C.; Alves de Lima, R. O.; Darros, B. R.; Barbisan, L. F.; de Camargo, J. L. Absence of chemopreventive influence of propolis on the rat liver altered foci development. Exp. Toxicol. Pathol. 2010, 62, 405-412.
145. Chung, T. W.; Moon, S. K.; Chang, Y. C.; Ko, J. H.; Lee, Y. C.; Cho, G.; Kim, S. H.; Kim, J. G.; Kim, H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 2004, 18, 1670-1681.
146. Mori, H.; Tanaka, T.; Shima, H.; Kuniyasu, T.; Takahashi, M. Inhibitory effect of chlorogenic acid on metylazoxymethanol acetate-induced carcinogenesis in large intestine and liver of hamsters. Cancer Lett. 1986, 30, 49-54.
147. 1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinine oxidoreducase in rat liver. Cancer Res. 2000, 60, 957-969.
148. Miyamoto, K.; Wakusawa, S.; Nomura, M.; Sanae, F.; Sakai, R.; Sudo, K.; Ohtaki, Y.; Takeda, S.; Ujii, Y. Effects of gomisin A on hepatocarcinogenesis by 3'-methyl-4-dimethylaminoazobenzene in rats. Jpn. J. Pharmacol. 1991, 57, 71-77.
149. Nomura, M.; Nakachiyama, M.; Hida, T.; Ohtaki, Y.; Sudo, K.; Aizawa, T.; Aburada, M.; Miyamoto, K. I. Gomisin A, a lignan component of Schizandora fruits, inhibits development of preneoplastic lesions in rat liver by 3'-methyl-4-dimethylaminoazobenzene. Cancer Lett. 1994, 76, 11-18.
150. Nomura, M.; Ohtaki, Y.; Hida, T.; Aizawa, T.; Wakita, H.; Miyamoto, K. Inhibition of early 3-methyl-4-dimethylaminoazobenzene-induced hepatocarcinogenesis by gomisin A in rats. Anticancer Res. 1994, 14, 1967-1972.
151. Ohtaki, Y.; Nomura, M.; Hida, T.; Miyamoto, K.; Kanitani, M.; Aizawa, T.; Aburada, M. Inhibition by gomisin A, a lignan compound, of hepatocarcinogenesis by 3'-methyl-4-dimethylaminoazobenzene in rats. Biol. Pharm. Bull. 1994, 17, 808-814.
152. Miyamoto, K.; Hiramatsu, K.; Ohtaki, Y.; Kanitani, M.; Nomura, M.; Aburada, M. Effects of gomisin A on the promoter action and serum bile acid concentration in hepatocarcinogenesis induced by 3'-methyl-4-dimethylamino-azobenzene. Biol. Pharm. Bull. 1995, 18, 1443-1445.
153. Ohtaki, Y.; Hida, T.; Hiramatsu, K.; Kanitani, M.; Ohshima, T.; Nomura, M.; Wakita, H.; Aburada, M.; Miyamoto, K. I. Deoxycholic acid as an endogenous risk factor for hepatocarcinogenesis and effects of gomisin A, a lignan component of Schizandra fruits. Anticancer Res. 1996, 16, 751-755.
154. Jang, J. J.; Cho, K. J.; Lee, Y. S.; Bae, J. H. Different modifying responses of capsaicin in a wide-spectrum initiation model of F344 rat. J. Korean Med. Sci. 1991, 6, 31-36.
155. 1 mice. Food Chem. Toxicol. 1998, 36, 1065-1071.
156. Agarwal, R. C.; Wiessler M.; Hecker E.; Bhide, S. V. Tumourpromoting effect of chilli extract in BALB/c mice. Int. J. Cancer 1986, 38, 689-695.
157. Jang, J. J.; Kim, S. H. The promoting effect of capsaicin on the development of diethylnitrosamine-initiated enzyme altered hepatic foci in male Sprague-Dawley rats. J. Korean Cancer Assoc. 1988, 20, 1-7.
158. Chuang, S. E.; Cheng, A. L.; Lin, J. K.; Kuo, M. L. Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem. Toxicol. 2000, 38, 991-995.
159. Chuang, S. E.; Kuo, M. L.; Hsu, C. H.; Chen, C. R.; Lin, J. K.; Lai, G. M.; Hsieh, C. Y.; Cheng, A. L. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 2000, 21, 331-335.
160. Thapliyal, R.; Naresh, K. N.; Rao, K. V. K.; Maru, G. B. Inhibition of nitrosodiethylamine-induced hepatocarcinogenesis by dietary turmeric in rats. Toxicol. Lett. 2003, 139, 45-54.
161. Shukla, Y.; Arora, A. Suppression of altered hepatic foci development by curcumin in Wistar rats. Nutr. Cancer 2003, 45, 53-59.
162. Sreepriya, M.; Bali, G. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia 2005, 76, 549-555.
163. Sreepriya, M.; Bali, G. Effects of administration of embelin and curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/ phenobarbital-induced hepatocarcinogenesis in Wistar rats. Mol. Cell. Biochem. 2006, 284, 49-55.
164. Huang, A. C.; Lin, S. Y.; Su, C. C.; Lin, S. S.; Ho, C. C; Hisa, T, C.; Chiu, T. H.; Yu, C. S.; Ip, S. W.; Lin, T. P.; Chung, J. G. Effects of curcumin on N-bis(2-hydroxypropyl) nitrosamine (DHPN)-induced lung and liver tumorigenesis in BALB/c mice in vivo. In Vivo 2008, 22, 781-786.
165. Takaba, K.; Hirose, M.; Yoshida, Y.; Kimura, J.; Ito, N.; Shirai, T. Effects of n-tritriacontane-16,18-dione, curcumin, chlorphyllin, dihydroguaiaretic acid, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model. Cancer Lett. 1997, 113, 39-46.
166. Frank, N.; Knauft, J.; Amelung, F.; Nair, J.; Wesch, H.; Bartsch, H. No prevention of liver and kidney tumors in Long-Evans Cinnamon rats by dietary curcumin, but inhibition at other sites and of metastases. Mutat. Res. 2003, 523-524, 127-135.
167. Busquets, S.; Carbó, N.; Alendro, V.; Quiles, M. T.; López-Soriano, F. J.; Argilés, J. M. Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model. Cancer Lett. 2001, 167, 33-38.
168. Ohashi, Y.; Tsuschiya, Y.; Koizumi, K.; Sakurai, H.; Saiki, I. Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 2003, 65, 250-258.
169. Cui, S. X.; Qu, X. J.; Xie, Y. Y.; Zhou, L.; Nakata, M.; Makuuchi, M.; Tang, W. Curcumin inhibits telomerase activity in human cancer cell lines. Int. J. Mol. Med. 2006, 18, 227-231.
170. Ning, L.; Wentworth, L.; Chen, H.; Weber, S.M. Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. Am. J. Transl. Res. 2009, 1, 358-366.
171. Yoysungnoen, P.; Wirachwong, P.; Bhattarakosol, P.; Niimi, H.; Patumraj, S. Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice. Clin. Hemorheol. Microcirc. 2005, 33, 127-135.
172. Yoysungnoen, P.; Wirachwong, P.; Bhattarakosol, P.; Niimi, H.; Patumraj, S.; Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin. Hemorheol. Microcirc. 2006, 34, 109-115.
173. Yoysungnoen, P.; Wirachwong, P.; Changtam, C.; Suksamrarn, A.; Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J. Gasterenterol. 2008, 14, 2003-2009.
174. Tanaka, T.; Iwata, H.; Niwa, K.; Mori, Y.; Mori, H. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats. Jpn. J. Cancer Res. 1988, 79, 1297-1303.
175. Jagan, S.; Ramakrishnan, G.; Anandakumar, P.; Kamaraj, S.; Devaki, T. Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma. Mol. Cell. Biochem. 2008, 319, 51-59.
176. Bishayee, A.; Bhatia, D.; Thoppil, R. J.; Darvesh, A. S.; Nevo, E.; Lansky, E. P. Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis 2011, 32, 888-896.
177. Bishayee, A.; Thoppil, R. J.; Darvesh, A. S.; Ohanyan, V.; Meszaros, J. G.; Bhatia, D. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically-induced rodent model of hepatocellular carcinogenesis. J. Nutr. Biochem. 2012, in press PMID: 22841394.
178. Tanaka, T.; Kojima, T.; Kawamori, T.; Yoshimi, N.; Mori, H. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Res. 1993, 53, 2775-2779.
179. Hirose, M.; Ozaki, K.; Takaba, K.; Fukushima, S.; Shirai, T.; Ito, N. Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model. Carcinogenesis 1991, 12, 1917-1921.
180. Nepka, C.; Sivridis, E.; Antonoglou, O.; Kortsaris, A.; Georgellis, A.; Taitzoglou, I.; Hytiroglou, P.; Papadimitriou, C.; Zintzaras, I.; Kouretas, D. Chemopreventive activity of very low dose dietary tannic acid administration in hepatoma bearing C3H male mice. Cancer Lett. 1999, 141, 57-62.
181. Taitzoglou, I. A.; Tsantarliotou, M. P.; Nepka, C.; Zervos, I.; Maltezos, E.; Kouretas, D.; Kokolis, N. A. Dietary administration of tannic acid lowers plasminogen activator activity in the liver of C3H hepatoma bearing male mice. In Vivo 2000, 14, 767-771.
182. Katzenellenbogen, M.; Mizrahi, L.; Pappo, O.; Klopstock, N.; Olam, D.; Jacob-Hirsch, J.; Amariglio, N.; Rechavi, G.; Domany, E.; Galun, E.; Goldenberg, D. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice. Mol. Cancer Res. 2007, 5, 1159-1170.
183. Bishayee, A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev. Res. 2009, 2, 409-418.
184. Bishayee, A.; Politis, T.; Darvesh, A. S. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat. Rev. 2010, 36, 43-53.
185. Bishayee, A.; Dhir, N. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem. Biol. Interact. 2009, 10, 131-144.
186. Bishayee, A.; Waghray, A.; Barnes, K.F.; Mbimba T.; Bhatia D.; Chatterjee, M.; Darvesh, A. S. Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis. Pharm. Res. 2010, 27, 1080-1091.
187. Bishayee, A.; Barnes K.F.; Bhatia, D.; Darvesh, A. S.; Carroll, R. T. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev. Res. 2010, 3, 753-763.
188. Mbimba, T.; Awale, P.; Bhatia, D.; Geldenhuys, W. J.; Darvesh, A.S.; Carroll, R. T.; Bishayee, A. Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis. Curr. Pharm. Biotechnol. 2012, 13, 229-234.
189. Bishayee, A.; Petit, D. M.; Samtani, K. Angioprevention is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis. J. Carcinog. Mutagen. 2010, 1, 102.
190. Luther, D. L.; Ohanyan, V.; Shamhart, P. E.; Hodnichak, C. M.; Sisakian, H.; Booth, T. D.; Meszaros, J.G.; Bishayee, A. Chemopreventive doses of resveratrol do not affect cardiac function in a rodent model of hepatocellular carcinoma. Invest. New Drugs 2011, 29, 380-391.
191. Carbó, N.; Costelli, P.; Baccino, F. M.; López-Soriano, F. J.; Argilés, J. M. Resveratrol, a natural product present in wine, decreases tumor growth in a rat tumor model. Biochem. Biophys. Res. Commun. 1999, 254, 739-743.
192. Miura, D.; Miura, Y.; Yagasaki, K. Hypolipidermic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci. 2003, 73, 1393-1400.
193. Liu, H. S.; Pan, C. E.; Yang, W.; Liu, X. M. Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J. Gastroenterol. 2003, 9, 1474-1476.
194. Yu, L.; Sun, Z. J.; Wu, S. L.; Pan, C. E. Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J. Gastroenterol. 2003, 9, 2341-2143.
195. Wu, S. L.; Sun, Z. J.; Yu, L.; Meng, K. W.; Qin, X. L.; Pan, C. E. Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J. Gastroenterol. 2004, 10, 3048-3052.
196. Yang, H. l.; Chen, W. Q.; Cao, X.; Worschech, A.; Du, L. F.; Fang, W. Y.; Xu, Y. Y.; Stroncek, D. F.; Li, X.; Wang, E.; Marincola, F. M. Caveolin-I enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model. J. Transl. Med. 2009, 7, 22.
197. Sakata, K.; Hara, A.; Hirose, Y.; Yamada, Y.; Kuno, T.; Katayama, M.; Yoshida, K.; Zheng, Q.; Murakami, A.; Ohigashi, H.; Ikemoto, K.; Koshimizu, K.; Tanaka, T.; Mori, H. Dietary supplementation of the citrus antioxidant auraptene inhibits N, N-diethylnitrosamineinduced rat hepatocarcinogenesis. Oncology 2004, 66, 244-52.
198. Hara, A.; Sakata, K.; Yamada, Y.; Kuno, T.; Kitaori, N.; Oyama, T.; Hirose, Y.; Murakami, A.; Tanaka, T.; Mori, H. Suppression of the-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N, N-diethylnitrosamine-induced hepatocellular carcinomas in rats. Oncol. Rep. 2005, 14, 345-351.
199. Jayakumar, S.; Madankumar, A.; Asokkumar, S.; Raghunandhakumar, S.; Gokula dhas, K.; Kamaraj, S.; Divya, M. G.; Devaki, T. Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol. Cell. Biochem. 2012, 360, 51-60.
200. Ong, T. P.; Heidor, R.; DeConti, A.; Dagli, M. L.; Moreno, F. S. Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGcoA reductase. Carcinogenesis 2006, 27, 1194-1203.
201. Cardozo, M. T.; de Conti, A.; Ong, T. P.; Scolastici, C.; Purgatto, E.; Horst, M. A.; Bassoli, B. K.; Moreno, F. S. Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. J. Nutr. Biochem. 2011, 22, 130-135.
202. Yu, S. G.; Hildebrandt, L. A.; Elson, C. E. Gerianol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. J. Nutr. 1995, 125, 2763-2767.
203. Giri, R. K.; Parija, T.; Das, B. R. d-Limonene chemoprevention of hepatocarcinogenesis in AKR mice: inhibition of c-jun and c-myc. Oncol. Rep. 1999, 6, 1123-1127.
204. Parija, T.; Das, R. B. Involvement of YY1 and its correlation with c-myc in NDEA induced hepatocarcinogenesis, its prevention by dlimonene. Mol. Biol. Rep. 2003, 30, 41-46.
205. RAS plasma membrane association. Int. J. Cancer 2001, 93, 441-444.
206. Bodake, H. B.; Panicker, K. N. S.; Kailaje, V. V.; Rao, K. V. K. Chemopreventive effect of orange oil on the development of hepatic preneoplastic lesions induced by N-nitrosodiethylamine in rats: an ultrastructural study. Ind. J. Expt. Biol. 2002, 40, 245-251.
207. Mills, J. J.; Chari, R. S.; Boyer, I. J.; Gould, M. N.; Jirtle, R. L. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res. 1995, 55, 979-983.
208. Löw-Baselli, A.; Huber, W. W.; Käfer, M.; Bukowska, K.; Schulte-Hermann, R.; Grasl-Kraupp, B. Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note. Carcinogenesis 2000, 21, 1869-1877.
209. Taha, M. M.; Abdul, A. B.; Abdullah, R.; Ibrahim, T. A.; Abdelwahab, S. I.; Mohan, S. Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet). Chem. Biol. Interact. 2010, 186, 295-305.
210. Espindola, R. M.; Mazzantini, R. P.; Ong, T. P.; de Conti, A.; Heidor, R.; Moreno, F. S. Geranylgeraniol and β-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-B activation. Carcinogenesis 2005, 26, 1091-1099.
211. Janani, P.; Sivakumari, K.; Geetha, A.; Ravisankar, B.; Parthasarathy, C. Chemopreventive effect of bacoside A on Nnitrosodiethylamine-induced hepatocarcinogenesis in rats. J. Cancer Res. Clin. Oncol. 2010, 136, 759-770.
212. Janani, P.; Sivakumari, K.; Geetha, A.; Ravisankar, B.; Parthasarathy, C. Bacoside A downregulates matrix metalloproteinases 2 and 9 in DENA-induced hepatocellular carcinoma. Cell Biochem. Funct. 2010, 28, 164-169.
213. Gayathri, R.; Priya, D. K.; Gunassekaran, G. R.; Sakthisekaran, D. Ursolic acid attenuates oxidative stress-mediated hepatocellular carcinoma induction by diethylnitrosamine in male Wistar rats. Asian Pac. J. Cancer Prev. 2009, 10, 933-938.
214. Tian, Z.; Lin, G.; Zheng, R. X.; Huang, F.; Yang, M. S.; Xiao, P. G. Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneana. World J. Gastroenterol. 2006, 14, 874-879.
215. Murakoshi, M.; Nishino, H.; Satomi, Y.; Takayasu, J.; Hasegawa, T.; Tokuda, H.; Iwashima, A.; Okuzumi, J.; Okabe, H.; Kitano, H.; Iwasaki, R. Potent preventive action of α-carotene against carcinogenesis: spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by α-carotene than by-carotene. Cancer Res. 1992, 52, 6583-6587.
216. Tsuda, H.; Iwahori, Y.; Asamoto, M.; Baba-Toriyami, H.; Hori, T.; Kim, D. J.; Uehara, N.; Ligo, M.; Takasuka, N.; Murakoshi, M.; Nishino, H.; Kakizoe, T.; Araki, E.; Yazawa, K. Demonstration of organotropic effects of chemopreventive agents in multiorgan carcinogenesis models. IARS Sci. Publ. 1996, 139, 143-150.
217. Astorg, P.; Gradelet, S.; Berges, R.; Suschetet, M. No evidence for an inhibitory effect of β-carotene or of canthaxanthin on the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr. Cancer 1996, 25, 27-34.
218. Astorg, P.; Gradelet, S.; Berges, R.; Suschetet, M. Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr. Cancer 1997, 29, 60-68.
219. Moreno, F. S.; Rizzi, M. B. S. L.; Dagli, M. L. Z.; Penteado, M. V. C. Inhibitory effects of β-carotene on preneoplastic lesions induced in Wistar rats by the resistant hepatocyte model. Carcinogenesis 1991, 12, 1817-1822.
220. Moreno, F. S.; Wu, T. S.; Penteado, M. V. C.; Rizzi, M. B. S. L.; Jordão Jr. A.; Almeida-Muradian, L. B.; Dagli, M. L. Z. A comparison of-carotene and vitamin A effects on a hepatocarcinogenesis model. Int. J. Vit. Nutr. Res. 1995, 65, 87-94.
221. Rizzi, M. B. S. L.; Dagli, M. L. Z.; Jordao Jr., A. A.; Penteado, M. V. C.; Moreno, F. S. Carotene inhibits persistent and stimulates remodeling γGT positive preneoplastic lesions during early promotion of hepatocarcinogenesis. Int. J. Vit. Nutr. Res. 1997, 67, 415-422.
222. Farber, E. Similarities in the sequence of early histological chances induced in the liver of the rat by ethionine, 2-acetylaminofluorene and 3'-methyl-4-dimethylaminoazobenzene. Cancer Res. 1956, 16, 142-148.
223. Dagli, M. L.; Guerra, J. L.; Sinhorini, I. L.; Wu, T. S.; Rizzi, M. B.; Penteado, M. V.; Moreno, F. S. Beta-carotene reduces the ductular (oval) cell reaction in the liver of Wistar rats submitted to the resistant hepatocyte model of carcinogenesis. Pathology 1998, 30, 259-266.
224. Moreno, F. S.; S-Wu, T.; Naves, M. M. V.; Silveira, E. R.; Oloris, S. C.; da Costa, A. L.; Dagli, M. L. Z.; Ong, T. P. Inhibitory effects of-carotene and vitamin A during the progression phase of hepatocarcinogenesis involve inhibition of cell proliferation but not alterations in DNA methylation. Nutr. Cancer 2002, 44, 80-88.
225. de Almeida Vasconcelos Fonseca, E. M.; Chagas, C. E.; Mazzantini R. P.; Heidor, R.; Ong, T. P.; Moreno, F. S. All-trans and 9-cis retinoic acids, retinol and β-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage. Carcinogenesis 2005, 26, 1940-1946.
226. Sampaio, A.; Chagas, C.; Ong, T.; Moreno, F. Vitamin A and β-carotene inhibitory effect during 1, 2-dimethylhydrazine induced hepatocarcinogenesis potentiated by 5-azacytidine. Food Chem. Toxicol. 2007, 45, 563-567.
227. Sarkar, A.; Mukherjee, B.; Chatterjee, M. Inhibitory effect of β-carotene on chronic 2-acetylaminofluorene induced hepatocarcinogenesis in rat: reflection in hepatic drug metabolism. Carcinogenesis 1994, 15, 1055-1060.
228. Sarkar, A.; Bishayee, A.; Chatterjee, M. Inhibition of 3'-methyl-4-dimethylaminoazobenzene-induced hepatocarcinogenesis in rat by dietary β-carotene: changes in hepatic anti-oxidant defense enzyme levels. Int. J. Cancer 1995, 61, 799-805.
229. Sarkar, A.; Bishayee, A.; Chatterjee, M. Beta-carotene prevents lipid peroxidation and red blood cell membrane protein damage in experimental hepatocarcinogenesis. Cancer Biochem. Biophys. 1995, 15, 111-125.
230. Sarkar, A.; Basak, R.; Bishayee, A.; Basak, J.; Chatterjee, M. β-Carotene inhibits rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosamine. Br. J. Cancer 1997, 76, 855-861.
231. Bishayee, A.; Sarkar, A.; Chatterjee, M. Further evidence for chemopreventive potential of β-carotene against experimental carcinogenesis: diethylnitrosamine-initiated and phenobarbitalpromoted hepatocarcinogenesis is prevented more effectively by β-carotene than by retinoic acid. Nutr. Cancer 2000, 37, 89-98.
232. Ogawa, T.; Higashi, S.; Kawarada, Y.; Mizumoto, R. Role of reactive oxygen in synthetic estrogen induction of hepatocellular carcinomas in rats and preventive effect of vitamins. Carcinogenesis 1995, 16, 831-836.
233. Uehara, N.; Iwahori, Y.; Asamoto, M.; Baba-Toriyama, H.; Iigo, M.; Ochiai, M.; Nagao, M.; Nakayama, M.; Degawa, M.; Matsumoto, K.; Hirono, I.; Beppu, H.; Fujita, K.; Tsuda, H. Decreased levels of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts in rats treated with-carotene, α-tocopherol and freeze-dried aloe. Jpn. J. Cancer Res. 1996, 87, 342-348.
234. 1 carcinogenicity, genotoxicity and metabolism in rat liver by dietary carotenoids: evidence for a protective effect of CYP1A inducers. Cancer Lett. 1997, 114, 221-223.
235. 1 metabolism. Carcinogenesis 1998, 19, 403-411.
236. Sadek, I. A.; Hayat, L. G. Initiation and post-initiation chemopreventive effects of-carotene in toad liver carcinogenesis. Histol. Histopathol. 1996, 11, 357-360.
237. Chattopadhyay, M. B.; Kumar, M. C. B.; Khanna, S.; Ray, R. S.; Roy, S.; Chatterjee, M. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferasepositive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis. J. Gastroenterol. Hepatol. 2004, 19, 683-693.
238. Chattopadhyay, M. B.; Mukherjee, S.; Kulkarni, I.; Vijayan, V.; Doloi, M.; Kanjilal, N. B.; Chatterjee, M. Proton-induced X-ray emission (PIXE) analysis and DNA-chain break study in rat hepatocarcinogenesis: a possible chemopreventive role by combined supplementation of vanadium and beta-carotene. Cancer Cell Int. 2005, 5, 16.
239. Bishayee, A.; Waghray, A.; Patel, M. A.; Chatterjee, M. Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence. Cancer Lett. 2010, 294, 1-12.
240. 1-induced hepatotoxic lesions by crocetin (a natural carotenoid). Carcinogenesis 1991, 10, 1807-1810.
241. Nishino, H. Cancer prevention by natural carotenoids. J. Cell. Biochem. 1997, 27, 86-91.
242. Toledo, L. P.; Ong, T. P.; Pinho, A. L. G.; Jordão Jr., A.; Vannucchi, H.; Moreno, F. S. Inhibitory effects of lutein and lycopene on placental glutathione S-transferase-positive preneoplastic lesions and DNA strand breakage induced in Wistar rats by the resistant hepatocyte model of hepatocarcinogenesis. Nutr. Cancer 2003, 47, 62-69.
243. Wang, Y.; Ausman, L. M.; Greenberg, A. S.; Russel, R. M.; Wang, X. D. Dietary lycopene and tomato extract supplementation inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats. Int. J. Cancer 2010, 126, 1788-1796.
244. Watanabe, S.; Kitade, Y.; Masaki, T.; Nishioka, M.; Satoh, K.; Nishino, H. Effects of lycopene and Sho-saiko-to on hepatocarcinogenesis in a rat model of spontaneous liver cancer. Nutr. Cancer 2001, 39, 96-101.
245. Scolastici, C.; Lopes, G. A. D.; Barbisan, L. F.; Salvadori, D. M. F. Tomato oleoresin inhibits DNA damage but not diethylnitrosamineinduced rat hepatocarcinogenesis. Expt. Toxicol. Pathol. 2008, 60, 59-68.
246. Tripathi, D. N.; Jena, G. B. Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes. Mutat. Res. 2010, 696, 69-80.
247. Moreno, F. S.; Toledo, L. P.; de Conti, A.; Heidor, R.; Jordão A. Jr.; Vannucchi, H.; Cardoza, M. T.; Ong, T. P. Lutein presents suppressing but not blocking chemopreventive activity during diethylnitrosamine-induced hepatocarcinogenesis and this involves inhibition of DNA damage. Chem. Biol. Interact. 2007, 20, 221-228.
248. 1 hepatocarcinogenesis in rainbow trout. Cancer Res. 1995, 55, 57-62.
249. Sugie, S.; Okamoto, K.; Makita, H.; Ohnishi, M.; Kawamori, T.; Watanabe, T.; Tanaka, T.; Mori, H. Inhibitory effect of chlorophyllin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. Jpn. J. Cancer Res. 1996, 87, 1045-1051.
250. Kensler, T. W.; Groopman, J. D.; Eaton, D. L.; Curphey, T. J.; Roebuck, B. D. Potent inhibition of aflatoxins-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis 1992, 13, 95-100.
251. Ogawa, K.; Hirose, M.; Sugiura, S.; Cui, L.; Imaida, K.; Ogiso, T.; Shirai T. Dose-dependent promotion by phenylehtyl isothicyanate, a known chemopreventer, of two-stage rat urinary balder and liver carcinogenesis. Nutr. Cancer 2001, 40, 134-139.
252. Lee, H. J.; Lee, S. A.; Choi, H. Dietary administration of inositol and/or inositol-6-phosphate prevents chemically-induced rat hepatocarcinogenesis. Asian Pac. J. Cancer Prev. 2005, 6, 41-47.
253. Sayed-Ahmed, M. M.; Aleisa, A. M.; Al-Rejaie, S. S.; Al-Yahya, A. A.; Al-Shabanah, O. A.; Hafez, M. M.; Nagi, M. N. Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signaling. Oxid. Med. Cell. Longev. 2010, 3, 254-261.
254. Gallus, S.; Bertuzzi, M.; Tavani, A.; Bosetti, C.; Negni, E.; La Vecchia, C.; Lagiou, P.; Trichopoulos, D. Does coffee protect against hepatocellular carcinoma? Br. J. Cancer 2002, 87, 956-959.
255. Gelatti, U.; Covolo, L.; Franceschini, M.; Pirali, F.; Tagger, A.; Ribero, M. L.; Trevisi, P.; Martelli, C.; Nardi, G.; Donato, F.; for the Brescia HCC study group. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a casecontrol study. J. Hepatol. 2005, 42, 528-534.
256. Shimazu, T.; Tsubono, Y.; Kuriyama, S.; Ohmori, K.; Koizumi, Y.; Nishino, Y.; Shibuya, D.; Tsuji, I. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int. J. Cancer 2005, 116, 150-154.
257. Leung, W. W.; Ho, S. C.; Chan, H. L. Y.; Wong, V.; Yeo, W.; Mok, T. S. K. Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a casecontrol study. J. Epidemiol. Community Health 2011, 65, 556-558.
258. Johnson, S.; Koh, W. P.; Wang, R.; Govindarajan, S.; Yu, M. C.; Yuan, J. M. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese health study. Cancer Causes Control 2011, 22, 503-510.
259. Egner, P. A.; Wang, J. B.; Zhu, Y. R.; Zhang, B. C.; Wu, Y.; Zhang, Q. N.; Qian, G. S.; Kuang, S. Y.; Gange, S. J.; Helzlsouer, K. J.; Bailey, G. S.; Groopman, J. D.; Kensler, T. W. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci. USA 2001, 98, 14601-14606.
260. Egner, P. A.; Munoz A.; Kensler, T. W. Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat. Res. 2003, 523-524, 209-216.
261. Luo, H., Tang, L.; Tang, M.; Billam, M.; Huang, T.; Yu, J.; Wei, Z.; Liang, Y.; Wang, K.; Zhang, Z. Q.; Zhang, L.; Wang, J. S. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 2006, 27, 262-268.
262. Seren, S.; Mutchnick, M.; Hutchinson, D.; Harmanci, O.; Bayraktar, Y.; Mutchnick, S; Sahin, K.; Kucuk, O. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma. Nutr. Cancer 2008, 60, 729-735.
263. 1-DNA adducts in healthy males. Carcinogenesis 1997, 18, 1189-1194.
264. Yu, M. W.; Chiu, Y. H.; Chiang, Y. C.; Chen, C. H.; Lee, T. H.; Santella, R. M.; Chern, H. D.; Liaw, Y. F.; Chen, C. J. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphoisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am. J. Epidemiol. 1999, 149, 621-629.
265. Nishino, H. Phytochemicals in hepatocellular cancer prevention. Nutr. Cancer 2009, 61, 789-791.
266. Isoda, N.; Eguchi, Y.; Nukaya, H.; Hosho, K.; Suga, Y.; Suga, T.; Nakazawa, S.; Sugano, K. Clinical efficacy of superfine dispersed lentinan (β-1,3-glucan) in patients with hepatocellular carcinoma. Hepatogastroenterolgy 2009, 56, 437-441.
267. Kurahashi, N.; Inoue, M.; Iwasaki, M.; Tanaka, Y.; Mizokami, M.; Tsugane, S.; for the JPHC study group. Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a populationbased prospective cohort of Japanese men and women. Int. J. Cancer 2009, 124, 1644-1649.
268. Howells, L. M.; Berry, D. P.; Elliott, P. J.; Jacobson, E. W.; Hoffmann, E.; Hegarty, B.; Brown, K.; Steward, W. P.; Gescher, A. J. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. Cancer Prev. Res. 2011, 4, 1419-1425.
269. Denda, A.; Endoh, T.; Tang, Q.; Tsujiuchi, T.; Nakae, D.; Konishi, Y. Prevention by inhibitors of arachidonic acid cascade of liver carcinogenesis, cirrhosis and oxidative DNA damage caused by a choline-deficient, L-amino acid defined diet in rats. Mutat. Res. 1998, 402, 279-288.
270. Manson, M. M.; Foreman, B. E.; Howells, L. M.; Moiseeva, E. P. Determining the efficacy of dietary phytochemicals in cancer prevention. Biochem. Soc. Trans. 2007, 35, 1358-1363.
271. Ramos, S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signaling pathways. Mol. Nutr. Food Res. 2008, 52, 507-526.
272. Oishi, N.; Wang, X. W. Novel therapeutic strategies for targeting liver cancer stem cells. Int. J. Biol. Sci. 2011, 7, 517-535.
273. Anand, P.; Kunnamakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4, 807-818.
274. Scheepens, A.; Tan, K.; Paxton, J. W. Improving the oral bioavailability of beneficial polyphenols through designed synergies. Genes Nutr. 2010, 5, 75-87.
275. Howells, L. M.; Moiseeva, E. P.; Neal, C. P.; Foreman, B. E.; Andreadi, C. K.; Sun, Y. Y.; Hudson, E. A.; Manson, M. M. Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol. Sin. 2007, 28, 1274-1304.
276. Seeram, N. P.; Adams, L. S.; Hardy, M. L.; Heber, D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J. Agric. Food Chem. 2004, 52, 2512-2517.
277. Lansky, E. P.; Jiang, W.; Mo, H.; Bravo, L.; Froom, P.; Yu, W.; Harris, N. M.; Neeman, I.; Campbell, M. J. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest. New Drugs 2005, 23, 11-20.
278. de Kok, T. M.; van Breda, S. G.; Manson, M. M. Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur. J. Nutr. 2008, 47, 51-59.
279. Zikri, N. N.; Riedl, K. M.; Wang, L. S.; Lechner, J.; Schwartz, S. J.; Stoner, G. D. Black raspberry components inhibit proliferation, induce apoptosis, and modulate gene expression in rat esophageal epithelial cells. Nutr. Cancer 2009, 61, 816-826.
280. Liu, R. H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 2004, 134, 3479S-3485S.
281. Li, L.; Braiteh, F. S.; Kurzrock, R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005, 104, 1322-1331.